Homeostasis and Inflammation in the Intestine Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Autoimmune Diseases
Autoimmune Diseases
Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
This study explores the mechanisms that regulate intestinal homeostasis and inflammation, focusing on how the immune system interacts with the gut microbiota. The gut is home to a complex community of microbes, and the ability of the immune system to coexist with these microbes is essential for maintaining health. Disruptions to this delicate balance can lead to chronic diseases like inflammatory bowel disease (IBD).
Who was studied?
The research examines both human and animal models, including mice and zebrafish, to investigate the interactions between intestinal cells, the immune system, and the microbiota. Special focus is given to the function of various immune cells and the epithelial barrier in the gut, as well as how these interactions change under conditions of disease or stress.
Most important findings
The study found that the gut microbiota plays a crucial role in shaping immune responses, maintaining intestinal homeostasis, and preventing inflammation. Specifically, the gut microbiota instructs immune cells, guiding their proper development and function. Disruptions to the gut barrier and microbial imbalance, often seen in conditions like Crohn’s disease and ulcerative colitis, can trigger inappropriate immune responses, leading to chronic inflammation. Cells such as Paneth cells, which produce antimicrobial peptides, are key in regulating the microbial community in the gut, and mutations in genes like ATG16L1 can impair their function, exacerbating disease. The integrity of the intestinal epithelium, including tight junctions, is also vital for maintaining homeostasis, and disruptions to this barrier can result in disease.
Key implications
The findings highlight the importance of microbial interactions in regulating immune responses and maintaining gut health. Understanding how the microbiota influences immune function and epithelial integrity could lead to new approaches for treating chronic inflammatory diseases. Therapies targeting microbial populations or modulating immune responses could offer promising treatments for diseases like IBD, where inflammation is driven by immune system dysregulation.
Crohn’s Disease
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that can cause a wide range of symptoms, including abdominal pain, diarrhea, and fatigue. The exact cause of the disease remains unclear, but it is believed to result from a combination of genetic predisposition and environmental factors. Although there is no cure, ongoing advancements in medical research continue to improve management strategies and quality of life for those affected by Crohn's disease.